Treatment of Smoldering Myeloma Cuts Progression Rate in Half

Published Date: 13 Dec 2024

Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

2.

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

3.

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

4.

AI tool automates liver tumor detection and monitoring

5.

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot